Premature ovarian failure has an autoimmune mechanism demonstrable in
25% of women. The autoimmune mechanisms involve depletion of regulator
y T cells and activation of self-reacted T cells through molecular mim
icry. Treatment of premature ovarian failure includes hormone replacem
ent therapy and, when fertility is desired, donor oocytes.